Bradbury Catch Ceo Nordisk Novo Rival Strategy
Daniel Bradbury, Amylin CEO, explains the company's pricing strategy in Europe and how it will catch up with rival Novo Nordisk.
CNBC | January 30, 2012
Tags:. .nordisk. .bradbury. .novo. .rival. .ceo